LIDIA-SEQ
LIVE

Serial Number

79448554

Owner

DNAE Group Holdings Limited

Filing Date

Mar 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LIDIA-SEQ Trademark

Serial Number: 79448554

LIDIA-SEQ is a trademark filed by DNAE Group Holdings Limited on March 16, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

DNAE Group Holdings Limited

Scale space,

Entity Type: 99

Trademark Details

Filing Date

March 16, 2026

Registration Date

Not Registered

Goods & Services

Scientific apparatus and instruments; scientific research and laboratory apparatus; apparatus for conducting PCR analysis; apparatus for DNA and RNA amplification and sequencing for research purposes; apparatus for semiconductor sequencing; apparatus for on-chip DNA and RNA amplification sequencing and measurement; silicon transistors; microchips; data processing equipment; computer software; bioinformatics software; software for microbial pathogen detection and identification; computer software for the diagnosis of sepsis, infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for scientific medical research and veterinary purposes; all for scientific research purposes.

Medical and veterinary apparatus and instruments; apparatus for providing diagnostic sequencing of blood samples, DNA and RNA; apparatus for microbial pathogen detection and identification; apparatus for the diagnosis and monitoring of sepsis and infectious diseases and associated antimicrobial resistance, cancer and other medical conditions; apparatus for DNA and RNA testing for medical purposes; apparatus for the diagnosis and monitoring of cancer; apparatus for testing blood samples, cancer cells, DNA, RNA and protein; apparatus for PCR analysis and DNA and RNA sequencing for medical and veterinary purposes; medical diagnostic apparatus for taking and storing blood samples; vials and other containers in the nature of tubes for blood and other medical sample collection; single use cartridges for use in medical apparatus for analysing biological samples; medical diagnostic test kits for the detecting, analysis and monitoring of medical conditions; medical diagnostic apparatus for testing patient biological samples and monitoring of patients; semiconductors and microchips for sequencing and measurement of DNA and RNA for medical and veterinary purposes.

Medical and veterinary services; healthcare services; DNA and RNA screening for medical purposes; genetic and blood testing, sequencing and measuring services; medical laboratory services for the analysis of samples taken from patients; provision of information relating to the analysis of DNA and RNA; genetic testing for medical purposes; genome sequencing and analysis services for medical and veterinary diagnostic and treatment purposes; medical diagnostic testing, monitoring and reporting services; consultancy and advisory services relating to the aforesaid services.

Scientific and technological services; laboratory services in the testing, sequencing and measurement of DNA and RNA; medical laboratory services; laboratory analysis; data storage services; software as a service (SaaS) services featuring software for genetic sequence analysis for screening and detecting diseases and reporting of test results for healthcare professionals and patients; consultancy and advisory services relating to the aforesaid services.

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 23, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2026 REPR